Utah 2023 Regular Session

Utah House Bill HB0024 Compare Versions

OldNewDifferences
1-Enrolled Copy H.B. 24
1+H.B. 24
2+LEGISLATIVE GENERAL COUNSEL
3+6 Approved for Filing: C. Williams 6
4+6 12-19-22 5:49 PM 6
5+H.B. 24
26 1 PRESCRIPTION DISCOUNT PROGRAM AMENDMENTS
37 2 2023 GENERAL SESSION
48 3 STATE OF UTAH
59 4 Chief Sponsor: Raymond P. Ward
610 5 Senate Sponsor: Michael S. Kennedy
711 6
812 7LONG TITLE
9-8General Description:
10-9 This bill allows the Public Employees' Benefit and Insurance Program (program) to add
11-10additional drugs to the prescription discount program.
12-11Highlighted Provisions:
13-12 This bill:
14-13 <modifies definitions;
15-14 <allows the Public Employees' Benefit and Insurance Program to add additional
16-15drugs to the prescription discount program;
17-16 <requires the program to notify the Legislature when an additional drug is added to
18-17the program; and
19-18 <makes technical changes.
20-19Money Appropriated in this Bill:
21-20 None
22-21Other Special Clauses:
23-22 None
24-23Utah Code Sections Affected:
25-24AMENDS:
26-25 49-20-421, as last amended by Laws of Utah 2021, Chapter 255
27-26
28-27Be it enacted by the Legislature of the state of Utah:
29-28 Section 1. Section 49-20-421 is amended to read:
30-29 49-20-421. Prescription discount program. H.B. 24 Enrolled Copy
13+8Committee Note:
14+9 The Health and Human Services Interim Committee recommended this bill.
15+10 Legislative Vote:12 voting for0 voting against 6 absent
16+11General Description:
17+12 This bill allows the Public Employees' Benefit and Insurance Program (program) to add
18+13additional drugs to the prescription discount program.
19+14Highlighted Provisions:
20+15 This bill:
21+16 <modifies definitions;
22+17 <allows the Public Employees' Benefit and Insurance Program to add additional
23+18drugs to the prescription discount program;
24+19 <requires the program to notify the Legislature when an additional drug is added to
25+20the program; and
26+21 <makes technical changes.
27+22Money Appropriated in this Bill:
28+23 None
29+24Other Special Clauses:
30+25 None
31+26Utah Code Sections Affected:
32+27AMENDS:
33+*HB0024* H.B. 24 12-19-22 5:49 PM
3134 - 2 -
32-30 (1) As used in this section:
33-31 [(a) "Diabetes" means:]
34-32 [(i) complete insulin deficiency or type 1 diabetes;]
35-33 [(ii) insulin resistant with partial insulin deficiency or type 2 diabetes; or]
36-34 [(iii) elevated blood glucose levels induced by pregnancy or gestational diabetes.]
37-35 [(b)] (a) "Discount program" means [a process developed by the program that allows
38-36participants to purchase a qualified prescription at a discounted, post-rebate rate] the
39-37prescription discount program created by this section.
40-38 [(c)] (b) "Epinephrine auto-injector" means the same as that term is defined in Section
41-3926-41-102.
42-40 [(d) "Individual with diabetes" means an individual who has been diagnosed with
43-41diabetes and who uses insulin to treat diabetes.]
44-42 [(e)] (c) "Insulin" means a prescription drug that contains insulin.
45-43 [(f)] (d) "Participant" means a resident of Utah who:
46-44 (i) [has a qualified condition] has a prescription or standing prescription for a qualified
47-45prescription;
48-46 (ii) does not receive health coverage under the program; and
49-47 (iii) enrolls in the discount program.
50-48 [(g)] (e) "Prescription drug" means the same as that term is defined in Section
51-4958-17b-102.
52-50 [(h) "Qualified condition" means the individual:]
53-51 [(i) uses insulin to treat diabetes; or]
54-52 [(ii) has a prescription or a standing prescription drug order for an epinephrine
55-53auto-injector issued under Section 58-17b-1005.]
56-54 [(i) "Qualified prescription" means:]
57-55 [(i) insulin; or]
58-56 [(ii) epinephrine auto-injector.]
59-57 (f) "Qualified prescription" means a prescription drug, including insulin and Enrolled Copy H.B. 24
35+28 49-20-421, as last amended by Laws of Utah 2021, Chapter 255
36+29
37+30Be it enacted by the Legislature of the state of Utah:
38+31 Section 1. Section 49-20-421 is amended to read:
39+32 49-20-421. Prescription discount program.
40+33 (1) As used in this section:
41+34 [(a) "Diabetes" means:]
42+35 [(i) complete insulin deficiency or type 1 diabetes;]
43+36 [(ii) insulin resistant with partial insulin deficiency or type 2 diabetes; or]
44+37 [(iii) elevated blood glucose levels induced by pregnancy or gestational diabetes.]
45+38 [(b)] (a) "Discount program" means [a process developed by the program that allows
46+39participants to purchase a qualified prescription at a discounted, post-rebate rate] the
47+40prescription discount program created by this section.
48+41 [(c)] (b) "Epinephrine auto-injector" means the same as that term is defined in Section
49+4226-41-102.
50+43 [(d) "Individual with diabetes" means an individual who has been diagnosed with
51+44diabetes and who uses insulin to treat diabetes.]
52+45 [(e)] (c) "Insulin" means a prescription drug that contains insulin.
53+46 [(f)] (d) "Participant" means a resident of Utah who:
54+47 (i) [has a qualified condition] has a prescription or standing prescription for a qualified
55+48prescription;
56+49 (ii) does not receive health coverage under the program; and
57+50 (iii) enrolls in the discount program.
58+51 [(g)] (e) "Prescription drug" means the same as that term is defined in Section
59+5258-17b-102.
60+53 [(h) "Qualified condition" means the individual:]
61+54 [(i) uses insulin to treat diabetes; or]
62+55 [(ii) has a prescription or a standing prescription drug order for an epinephrine
63+56auto-injector issued under Section 58-17b-1005.]
64+57 [(i) "Qualified prescription" means:]
65+58 [(i) insulin; or] 12-19-22 5:49 PM H.B. 24
6066 - 3 -
61-58epinephrine auto-injectors, that the program has determined:
62-59 (i) treats a serious, prevalent, and ongoing condition;
63-60 (ii) does not have a generic substitute;
64-61 (iii) qualifies for a substantial rebate; and
65-62 (iv) would not result in financial losses to the state risk pool if sold as part of the
66-63discount program.
67-64 [(j)] (g) "Rebate" means the same as that term is defined in Section 31A-46-102.
68-65 (2) [Notwithstanding Subsection 49-20-201(1), and for the purpose of the discount
69-66program only, the program shall offer a discount program that allows participants to purchase a
70-67qualified prescription at a discounted, post-rebate price when a rebate is available.] The
71-68program shall create a prescription discount program for a participant to purchase a qualified
72-69prescription at a discounted, post-rebate price.
73-70 (3) The [discount] program [described in Subsection (2)] shall:
74-71 (a) provide a participant with a card or electronic document that identifies the
75-72participant as eligible for the discount on a qualified prescription [related to the participant's
76-73qualified condition];
77-74 (b) provide a participant with information about pharmacies that will honor the
78-75discount; and
79-76 [(c) allow a participant to purchase a qualified prescription at a discounted, post-rebate
80-77price; and]
81-78 [(d)] (c) provide a participant with instructions to pursue a reimbursement of the
82-79purchase price from the participant's health insurer.
83-80 [(4) The discount program shall charge a price for a qualified prescription that allows
84-81the program to retain only enough of any rebate for the qualified prescription to make the state
85-82risk pool whole for providing a discounted qualified prescription to participants.]
86-83 (4) The program may not retain any amount of a rebate for a qualified prescription
87-84except for an amount necessary to make the state risk pool whole for providing the qualified
88-85prescription to participants. H.B. 24 Enrolled Copy
67+59 [(ii) epinephrine auto-injector.]
68+60 (f) "Qualified prescription" means a prescription drug, including insulin and
69+61epinephrine auto-injectors, that the program has determined:
70+62 (i) treats a serious, prevalent, and ongoing condition;
71+63 (ii) does not have a generic substitute;
72+64 (iii) qualifies for a substantial rebate; and
73+65 (iv) would not result in financial losses to the state risk pool if sold as part of the
74+66discount program.
75+67 [(j)] (g) "Rebate" means the same as that term is defined in Section 31A-46-102.
76+68 (2) [Notwithstanding Subsection 49-20-201(1), and for the purpose of the discount
77+69program only, the program shall offer a discount program that allows participants to purchase a
78+70qualified prescription at a discounted, post-rebate price when a rebate is available.] The
79+71program shall create a prescription discount program for a participant to purchase a qualified
80+72prescription at a discounted, post-rebate price.
81+73 (3) The [discount] program [described in Subsection (2)] shall:
82+74 (a) provide a participant with a card or electronic document that identifies the
83+75participant as eligible for the discount on a qualified prescription [related to the participant's
84+76qualified condition];
85+77 (b) provide a participant with information about pharmacies that will honor the
86+78discount; and
87+79 [(c) allow a participant to purchase a qualified prescription at a discounted, post-rebate
88+80price; and]
89+81 [(d)] (c) provide a participant with instructions to pursue a reimbursement of the
90+82purchase price from the participant's health insurer.
91+83 [(4) The discount program shall charge a price for a qualified prescription that allows
92+84the program to retain only enough of any rebate for the qualified prescription to make the state
93+85risk pool whole for providing a discounted qualified prescription to participants.]
94+86 (4) The program may not retain any amount of a rebate for a qualified prescription
95+87except for an amount necessary to make the state risk pool whole for providing the qualified
96+88prescription to participants.
97+89 (5) For each drug added to the discount program, the program shall notify the Health H.B. 24 12-19-22 5:49 PM
8998 - 4 -
90-86 (5) For each drug added to the discount program, the program shall notify the Health
91-87and Human Services Interim Committee, providing:
92-88 (a) the name of the drug; and
93-89 (b) the primary condition the drug treats.
99+90and Human Services Interim Committee, providing:
100+91 (a) the name of the drug; and
101+92 (b) the primary condition the drug treats.